These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12220612)

  • 1. Treatment of methamphetamine use disorders: an update.
    Rawson RA; Gonzales R; Brethen P
    J Subst Abuse Treat; 2002 Sep; 23(2):145-50. PubMed ID: 12220612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence.
    Chen H; Wu J; Zhang J; Hashimoto K
    Curr Drug Abuse Rev; 2010 Dec; 3(4):222-38. PubMed ID: 21208168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine abuse.
    Winslow BT; Voorhees KI; Pehl KA
    Am Fam Physician; 2007 Oct; 76(8):1169-74. PubMed ID: 17990840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
    Shoptaw S; Reback CJ; Peck JA; Yang X; Rotheram-Fuller E; Larkins S; Veniegas RC; Freese TE; Hucks-Ortiz C
    Drug Alcohol Depend; 2005 May; 78(2):125-34. PubMed ID: 15845315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
    Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction time variability and related brain activity in methamphetamine psychosis.
    Fassbender C; Lesh TA; Ursu S; Salo R
    Biol Psychiatry; 2015 Mar; 77(5):465-74. PubMed ID: 25444164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug sensitization induced by prenatal methamphetamine exposure.
    Macúchová E; Slamberová R
    Cesk Fysiol; 2016 Oct; 65(1):32-37. PubMed ID: 29489090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of methamphetamine abuse: research findings and clinical directions.
    Cretzmeyer M; Sarrazin MV; Huber DL; Block RI; Hall JA
    J Subst Abuse Treat; 2003 Apr; 24(3):267-77. PubMed ID: 12810148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine abuse: issues for special populations.
    Freese TE; Obert J; Dickow A; Cohen J; Lord RH
    J Psychoactive Drugs; 2000; 32(2):177-82. PubMed ID: 10908005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of the methamphetamine problem.
    Anglin MD; Burke C; Perrochet B; Stamper E; Dawud-Noursi S
    J Psychoactive Drugs; 2000; 32(2):137-41. PubMed ID: 10908000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: an emerging profile.
    von MC; Brecht ML; Anglin MD
    J Addict Dis; 2002; 21(1):45-60. PubMed ID: 11831499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for speed: an update on methamphetamine addiction.
    Barr AM; Panenka WJ; MacEwan GW; Thornton AE; Lang DJ; Honer WG; Lecomte T
    J Psychiatry Neurosci; 2006 Sep; 31(5):301-13. PubMed ID: 16951733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health outcomes associated with methamphetamine use among young people: a systematic review.
    Marshall BD; Werb D
    Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between impulsivity and methamphetamine use severity in a community sample.
    Moallem NR; Courtney KE; Ray LA
    Drug Alcohol Depend; 2018 Jun; 187():1-7. PubMed ID: 29626740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life among treatment seeking methamphetamine-dependent individuals.
    Gonzales R; Ang A; Glik DC; Rawson RA; Lee S; Iguchi MY;
    Am J Addict; 2011; 20(4):366-72. PubMed ID: 21679268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users.
    Díaz RM; Heckert AL; Sánchez J
    J Urban Health; 2005 Mar; 82(1 Suppl 1):i71-8. PubMed ID: 15738318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingency management: an evidence-based component of methamphetamine use disorder treatments.
    Roll JM
    Addiction; 2007 Apr; 102 Suppl 1():114-20. PubMed ID: 17493060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.